Yan-zhen Li , Fu-qiu Liang , Shi-zhu Lin , Kai Zeng , Hong-da Cai , Min Liang
{"title":"Advanced glycation end products induce autophagy in endothelial cells through oxidative stress and regulation of the RhoA-mTOR signaling pathway","authors":"Yan-zhen Li , Fu-qiu Liang , Shi-zhu Lin , Kai Zeng , Hong-da Cai , Min Liang","doi":"10.1016/j.imbio.2025.153088","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Advanced glycation end product (AGE)-induced oxidative stress in human umbilical vein endothelial cells (HUVECs) is closely associated with the miR-200b-RhoA signaling axis. Rho-associated protein kinase (RhoA) can crosstalk with the mammalian target of rapamycin (mTOR) complex 1. This study investigated the role of the RhoA-mTOR signaling pathway in autophagy induced in HUVECs by AGEs. In the present study, more severe oxidative damage was found in the HUVECs with AGE-induced autophagy.</div></div><div><h3>Methods</h3><div>We set 5 different concentrations and times respectively, by comparing the cell proliferation changes at different intervention concentrations at each intervention time point and calculating the oxidative stress indicators at four time points, we found that 200 μg/L AGEs intervention for 6 h is the best concentration and time. The expression of RhoA, ROCK, and mTOR was decreased after AGE stimulation, and increased after inhibition of RhoA. Further, we constructed two retroviral plasmids to express constitutively active (Q63LRhoA) or loss-of-function (T19NRhoA) RhoA, and obtained stably transfected HUVECs.</div></div><div><h3>Results</h3><div>There was a statistically significant difference in mTOR mRNA expression between Q63LRhoA and T19NRhoA cells. In summary, AGEs induced oxidative damage and autophagy in HUVECs, which may be related to synchronous regulation of the RhoA-mTOR signaling pathway.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 4","pages":"Article 153088"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunobiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0171298525002220","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Advanced glycation end product (AGE)-induced oxidative stress in human umbilical vein endothelial cells (HUVECs) is closely associated with the miR-200b-RhoA signaling axis. Rho-associated protein kinase (RhoA) can crosstalk with the mammalian target of rapamycin (mTOR) complex 1. This study investigated the role of the RhoA-mTOR signaling pathway in autophagy induced in HUVECs by AGEs. In the present study, more severe oxidative damage was found in the HUVECs with AGE-induced autophagy.
Methods
We set 5 different concentrations and times respectively, by comparing the cell proliferation changes at different intervention concentrations at each intervention time point and calculating the oxidative stress indicators at four time points, we found that 200 μg/L AGEs intervention for 6 h is the best concentration and time. The expression of RhoA, ROCK, and mTOR was decreased after AGE stimulation, and increased after inhibition of RhoA. Further, we constructed two retroviral plasmids to express constitutively active (Q63LRhoA) or loss-of-function (T19NRhoA) RhoA, and obtained stably transfected HUVECs.
Results
There was a statistically significant difference in mTOR mRNA expression between Q63LRhoA and T19NRhoA cells. In summary, AGEs induced oxidative damage and autophagy in HUVECs, which may be related to synchronous regulation of the RhoA-mTOR signaling pathway.
期刊介绍:
Immunobiology is a peer-reviewed journal that publishes highly innovative research approaches for a wide range of immunological subjects, including
• Innate Immunity,
• Adaptive Immunity,
• Complement Biology,
• Macrophage and Dendritic Cell Biology,
• Parasite Immunology,
• Tumour Immunology,
• Clinical Immunology,
• Immunogenetics,
• Immunotherapy and
• Immunopathology of infectious, allergic and autoimmune disease.